93 related articles for article (PubMed ID: 12615201)
1. Akt is TCL-ish: implications for B-cell lymphoma.
Gold MR
Trends Immunol; 2003 Mar; 24(3):104-8. PubMed ID: 12615201
[No Abstract] [Full Text] [Related]
2. B-cell lymphoma: suppressing a tumor suppressor.
Dent A
Nat Med; 2005 Jan; 11(1):22. PubMed ID: 15635439
[No Abstract] [Full Text] [Related]
3. A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane.
French SW; Shen RR; Koh PJ; Malone CS; Mallick P; Teitell MA
Biochemistry; 2002 May; 41(20):6376-82. PubMed ID: 12009899
[TBL] [Abstract][Full Text] [Related]
4. Akt-dependent phosphorylation negatively regulates the transcriptional activity of dHAND by inhibiting the DNA binding activity.
Murakami M; Kataoka K; Fukuhara S; Nakagawa O; Kurihara H
Eur J Biochem; 2004 Aug; 271(16):3330-9. PubMed ID: 15291810
[TBL] [Abstract][Full Text] [Related]
5. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.
Biggs WH; Meisenhelder J; Hunter T; Cavenee WK; Arden KC
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7421-6. PubMed ID: 10377430
[TBL] [Abstract][Full Text] [Related]
8. TCL1: a new drug target in lymphoid and germ-cell malignancies?
Lock RB
Int J Biochem Cell Biol; 2003 Dec; 35(12):1614-8. PubMed ID: 12962701
[TBL] [Abstract][Full Text] [Related]
9. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.
Brunet A; Bonni A; Zigmond MJ; Lin MZ; Juo P; Hu LS; Anderson MJ; Arden KC; Blenis J; Greenberg ME
Cell; 1999 Mar; 96(6):857-68. PubMed ID: 10102273
[TBL] [Abstract][Full Text] [Related]
10. A random walk in oncogene space: the quest for targets.
Vogt PK; Aoki M; Bottoli I; Chang HW; Fu S; Hecht A; Iacovoni JS; Jiang BH; Kruse U
Cell Growth Differ; 1999 Dec; 10(12):777-84. PubMed ID: 10616902
[No Abstract] [Full Text] [Related]
11. Akt phosphorylates and regulates the orphan nuclear receptor Nur77.
Pekarsky Y; Hallas C; Palamarchuk A; Koval A; Bullrich F; Hirata Y; Bichi R; Letofsky J; Croce CM
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3690-4. PubMed ID: 11274386
[TBL] [Abstract][Full Text] [Related]
12. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.
Li YM; Zhou BP; Deng J; Pan Y; Hay N; Hung MC
Cancer Res; 2005 Apr; 65(8):3257-63. PubMed ID: 15833858
[TBL] [Abstract][Full Text] [Related]
13. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.
Fujita T; Fukuyama R; Enomoto H; Komori T
J Cell Biochem; 2004 Oct; 93(2):374-83. PubMed ID: 15368363
[TBL] [Abstract][Full Text] [Related]
15. Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells.
Zhu W; Bijur GN; Styles NA; Li X
Brain Res Mol Brain Res; 2004 Jul; 126(1):45-56. PubMed ID: 15207915
[TBL] [Abstract][Full Text] [Related]
16. Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage.
Wanzel M; Kleine-Kohlbrecher D; Herold S; Hock A; Berns K; Park J; Hemmings B; Eilers M
Nat Cell Biol; 2005 Jan; 7(1):30-41. PubMed ID: 15580267
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
18. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
[TBL] [Abstract][Full Text] [Related]
19. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
Cannon ML; Cesarman E
Oncogene; 2004 Jan; 23(2):514-23. PubMed ID: 14724579
[TBL] [Abstract][Full Text] [Related]
20. Identification of AKT-regulated genes in inducible MERAkt cells.
Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
